US EditionInstil Bio Appoints 'Seasoned' Biopharma Exec as Chief Medical Officer
Summary by Dallas Innovates
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Instil Bio Appoints 'Seasoned' Biopharma Exec as Chief Medical Officer
Dallas Innovates, Every Day: Here's what's new + next in North Texas. Dallas-based biopharma company Instil Bio Inc. has appointed Jamie Freedman, M.D., PhD., as chief medical officer, bringing with him extensive experience in oncology drug development and other therapeutic areas. Instil said that Freedman has a track record of leading programs through all phases of development, regulatory approval, and commercialization.…The post Instil Bio App…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
